March 6th 2023
Pembrolizumab also appears to garner modest anti-tumor activity regardless of PD-L1 expression in patients with advanced thyroid cancer.
Physical Exams Adequate to Detect Thyroid Cancer in Cancer SurvivorsFebruary 3rd 2016
The use of a standard yearly physical examination to screen for thyroid cancer among high-risk survivors of childhood and young adult cancers resulted in a negative predictive value of 100% for clinically relevant thyroid cancer and a significant cost savings compared with regular ultrasound screening.
Novel Gene Found Related to Cowden Syndrome, Thyroid CancerNovember 6th 2015
Researchers identified a novel gene that may predispose individuals to Cowden syndrome, an inherited condition that carries an especially high risk for various epithelial cancers and especially thyroid cancer.
Markers in Medullary Thyroid Cancer May Signal Metastasis, Vandetanib ResponseOctober 22nd 2015
Researchers in Germany appear to have identified a gene-expression signature associated with metastasis in sporadic medullary thyroid cancer and prognostic molecular tumor markers of medullary thyroid cancer response to vandetanib therapy.
Superior Survival Seen With Aggressive Therapy in Anaplastic Thyroid CancerOctober 21st 2015
For patients who can tolerate aggressive multimodal therapy for anaplastic thyroid carcinoma, survival rates can exceed historical outcomes, according to a retrospective study of patients treated at the Mayo Clinic.
Role of Fukushima Radiation Unclear in Pediatric Thyroid Cancers?October 21st 2015
It is too soon to determine the influence of radiation exposure on thyroid cancer risk among children and adolescents exposed to the 2011 Fukushima Daiichi nuclear power plant disaster in Japan, according to the lead author of findings presented at the 85th Annual Meeting of the ATA.
Increased Risk of Second Malignancies With Radioactive Iodine Therapy for Thyroid CancerApril 27th 2015
A new population-based study has found that patients with thyroid cancer who are treated with radioactive iodine therapy are at increased risk for developing salivary cancer as a second malignancy.
Breast Cancer Survivors at Increased Risk for Thyroid CancerApril 24th 2015
A recent study found that women diagnosed with breast cancer are at increased risk for developing thyroid cancer, prompting the authors to encourage regular screening for the disease in breast cancer survivors.